Disc Medicine, Inc.
IRON
Rank in Stocks
#4957
Based in Watertown, Massachusetts, Disc Medicine, Inc. operates as a... Based in Watertown, Massachusetts, Disc Medicine, Inc. operates as a clinical-stage biotechnology company. Its core mission involves the discovery, development, and commercialization of novel therapeutic solutions for individuals suffering from serious hematological diseases. The company is actively constructing a pipeline of drug candidates, designed to address a variety of these conditions by precisely targeting fundamental biological mechanisms related to red blood cell biology, particularly heme biosynthesis and iron homeostasis.
Share Price
$75.39
Last synced: 2026-10-22
Market Cap
$2.89B
Change (1 day)
-0.80%
Change (1 year)
-9.92%
Country
US
Trade Disc Medicine, Inc. (IRON)
Category
Healthcare
P/E ratio for Disc Medicine, Inc. (IRON)
P/E ratio as of October 2026 TTM: -11.74
According to Disc Medicine, Inc. latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -11.74. At the end of 2024 the company had a P/E ratio of -16.00.
P/E ratio history for Disc Medicine, Inc. from 2020 to 2026
P/E ratio at the end of each year
| Year | P/E Ratio | Change |
|---|---|---|
| 2026 (TTM) | -11.74 | -11.16% |
| 2025 | -13.21 | -17.44% |
| 2024 | -16.00 | -5.10% |
| 2023 | -16.86 | 3,719.91% |
| 2022 | -0.44 | -31.91% |
| 2021 | -0.65 | -84.07% |
| 2020 | -4.07 | 0.00% |
P/E ratio for similar companies or competitors
| Company | P/E Ratio | P/E Ratio Difference | Country |
|---|---|---|---|
| 30.83 | -362.73% |
US
|
|
| -29.16 | 148.50% |
US
|
|
| -25.99 | 121.48% |
AU
|
|
| 22.43 | -291.15% |
BE
|
|
| 31.22 | -366.00% |
NL
|
How to read a P/E ratio?
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share.
A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.